Related Experiment Video
Updated: Jan 13, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Cognitive Functioning in Phenylketonuria: A Lifespan Perspective
Stephan Huijbregts1, Cristina Romani2
1Education and Child Studies, Leiden Institute for Brain and Cognition, Leiden University, 2333 AK Leiden, The Netherlands.
Insights
Phenylketonuria (PKU) research needs more studies on young children and older adults. Understanding cognitive function in these PKU patients is crucial for development and aging.
Area of Science:
- Metabolic disorders
- Neuroscience
- Developmental psychology
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder.
- It causes phenylalanine buildup, leading to cognitive impairment.
- Current research on PKU cognitive outcomes primarily focuses on school-aged children, adolescents, and young adults.
Purpose of the Study:
- To highlight the need for research on cognitive functioning in very young and older individuals with PKU.
- To emphasize the importance of early cognitive development for long-term outcomes.
- To explore the potential impact of PKU and metabolic control on age-related cognitive decline.
Main Methods:
- This is a review article.
- It synthesizes existing literature on PKU and cognitive function.
- It identifies gaps in current research.
Main Results:
- There is a lack of studies on the cognitive functioning of very young and older PKU patients.
- Early cognitive development is critical for later cognitive and behavioral functioning.
- Metabolic control in PKU may influence age-related cognitive decline.
Conclusions:
- Further research is essential to understand cognitive development and aging in individuals with PKU.
- Investigating cognitive function across the lifespan in PKU is crucial for comprehensive patient care.
- Addressing research gaps will inform interventions and improve long-term outcomes for PKU patients.
Abstract:
Phenylketonuria (PKU) is a hereditary metabolic disorder characterized by the inability to metabolize phenylalanine, leading to neurotoxic accumulation of phenylalanine and significant cognitive impairment. While extensive research has focused on the cognitive outcomes in middle childhood, adolescence, and early adulthood, there is a notable paucity of studies addressing the cognitive functioning of very young and older PKU patients. This review underscores the necessity for further research in these populations, particularly because of the importance of early cognitive development for later cognitive and behavioral functioning and because of the potential implications of PKU and metabolic control for age-related cognitive decline.
More Related Videos
11:29Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cognitive Development During Adulthood
Information Processing Approach
Revisionist Views of Adolescent and Adult Cognition
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption